Artivion | CRY - Current Liabilities


Artivion reported $106.93M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
AngioDynamics USD 71.96M 3.68M Sep/2025
Artivion USD 106.93M 14.23M Jun/2026
AtriCure USD 81.92M 8.72M Jun/2026
Baxter International USD 3.59B 102M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Boston Scientific USD 6.43B 1.86B Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Integra LifeSciences USD 330.88M 15.96M Jun/2026
J&J USD 54.9B 2.82B Jun/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
Orthofix International USD 157.01M 4.02M Jun/2026
Pfizer USD 32.65B 1.7B Jun/2026
ResMed USD 1.4B 43.9M Jun/2026
Stryker USD 6.68B 369M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Terumo JPY 413.28B 127.46B Jun/2026
Trinity Biotech USD 141.21M 106.72M Dec/2025